Expression Diagnostics

CareDx is a leading precision medicine company focused on the discovery, development, and commercialization of high-value diagnostic solutions for transplant patients and their caregivers. The company provides a comprehensive suite of testing services and products across the transplant journey, including pre-transplant donor matching and post-transplant surveillance. Its flagship products, AlloMap and AlloSure, utilize gene expression profiling and next-generation sequencing to monitor organ health and detect early signs of rejection non-invasively. CareDx is committed to improving long-term outcomes for transplant recipients through innovative genomic-based information and digital health solutions. The company also offers digital health tools and laboratory products to support the transplant ecosystem globally.